Report Detail
Global Drug Delivery Devices Market By Route of Administration [Oral, Injectable, Nasal, Topical, Ocular, Implantable and others],By Application [Infectious Diseases, Autoimmune Diseases, Cancer, Central Nervous System Disorders, Cardiovascular Diseases, Respiratory Diseases ,Diabetes and others], By End User[Hospitals and Clinics, Home Care Settings and Diagnostic Centers]: Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecas
- RnM4291080 |
- 16 March, 2021 |
- Global |
- 200 Pages |
- Transilience Market Research |
- Healthcare
Global Drug Delivery Devices Market 2020 By Route of Administration [Oral, Injectable, Nasal, Topical, Ocular, Implantable and others],By Application [Infectious Diseases, Autoimmune Diseases, Cancer, Central Nervous System Disorders, Cardiovascular Diseases, Respiratory Diseases ,Diabetes and others], By End User[Hospitals and Clinics, Home Care Settings and Diagnostic Centers]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Drug Delivery Devices Market is valued at 1.25 USD Billion in 2019 and expected to reach USD 2.25 Billion by 2026 with the CAGR of 8.68% over the forecast period.
Scope of the report
This report analyses the global market for Drug Delivery Devices. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
Gerresheimer AG,Sanofi,Johnson & Johnson Services, Inc.,Bayer AG,GlaxoSmithKline plc,Enable Injections,West Pharmaceutical Services, Inc.,SMC Ltd.,ViVO Smart Medical Devices Ltd.,Cipla Inc,Novosanis,MEDMIX SYSTEMS AG,Merck & Co., Inc.,Pfizer Inc.,Insulet Corporation,OraSure Technologies, Inc.,BD.,F. Hoffmann-La Roche Ltd,Antares Pharma,Novartis AG,3M,Sulzer Ltd and others
Above mentioned companies were scrutinized to assess competitive landscape of global Drug Delivery Devices market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period: (2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Billion
This Drug Delivery Devices market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Route of Administration
o Oral
o Injectable
o Nasal
o Topical
o Ocular
o Implantable
• Application
o Infectious Diseases
o Autoimmune Diseases
o Cancer
o Central Nervous System Disorders
o Cardiovascular Diseases
o Respiratory Diseases
o Diabetes
• End User
o Hospitals and Clinics
o Home Care Settings
o Diagnostic Centers
Report Coverage
• An overview of the global Drug Delivery Devices market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Drug Delivery Devices market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Drug Delivery Devices market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Drug Delivery Devices Market Report
• What is the impact of COVID 19 epidemic on the global Drug Delivery Devices market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Drug Delivery Devices market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Drug Delivery Devices market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
- 3.1. Market Definition
- 3.2. Market Scope
- 3.3. Market Drivers
- 3.4. Market Restraints
- 3.5. Market Opportunities and Trends
- 3.6. Porter’s five force analysis
- 3.7. SWOT Analysis
- 3.8. PEST Analysis
- 3.9. Patent Analysis
- 3.10. Impact of COVID 19 on Global Drug Delivery Devices Market
4. Drug Delivery Devices Market, By Route of Administration, Market Size and Forecast 2016 -2026 (USD Billion)
- 4.1. Global Drug Delivery Devices Market By Route of Administration, 2016 -2026 (USD Billion)
- 4.1.1. Global Drug Delivery Devices Market By Oral
- 4.1.2. Global Drug Delivery Devices Market By Injectable
- 4.1.3. Global Drug Delivery Devices Market By Nasal
- 4.1.4. Global Drug Delivery Devices Market By Topical
- 4.1.5. Global Drug Delivery Devices Market By Ocular
- 4.1.6. Global Drug Delivery Devices Market By Implantable
- 4.1.7. Global Drug Delivery Devices Market By Diabetes
- 4.2. Global Drug Delivery Devices Market By Route of Administration Share, 2016 -2026 (%)
5. Drug Delivery Devices Market, By Application, Market Size and Forecast 2016 -2026 (USD Billion)
- 5.1. Global Drug Delivery Devices Market By Application, 2016 -2026 (USD Billion)
- 5.1.1. Global Drug Delivery Devices Market By Infectious Diseases
- 5.1.2. Global Drug Delivery Devices Market By Autoimmune Diseases
- 5.1.3. Global Drug Delivery Devices Market By Cancer
- 5.1.4. Global Drug Delivery Devices Market By Central Nervous System Disorders
- 5.1.5. Global Drug Delivery Devices Market By Cardiovascular Diseases
- 5.1.6. Global Drug Delivery Devices Market By Respiratory Diseases
- 5.2. Global Drug Delivery Devices Market By Application Share, 2016 -2026 (%)
6. Drug Delivery Devices Market, By End User, Market Size and Forecast 2016 -2026 (USD Billion)
- 6.1. Global Drug Delivery Devices Market By End User, 2016 -2026 (USD Billion)
- 6.1.1. Global Drug Delivery Devices Market By Hospitals and Clinics
- 6.1.2. Global Drug Delivery Devices Market By Home Care Settings
- 6.1.3. Global Drug Delivery Devices Market By Diagnostic Centers
- 6.2. Global Drug Delivery Devices Market By End User Share, 2016 -2026 (%)
7. Drug Delivery Devices Market, By Region Market Size and Forecast 2016 -2026
- 7.1. NORTH AMERICA
- 7.1.1. Key Findings
- 7.1.2. Impact of COVID 19
- 7.1.3. Key market trends, growth factors and opportunities
- 7.1.4. North America Drug Delivery Devices Market by Country 2016 -2026 (USD Billion)
- 7.1.5. North America Drug Delivery Devices Market By Route of Administration 2016 -2026 (USD Billion)
- 7.1.6. North America Drug Delivery Devices Market By Application 2016 -2026 (USD Billion)
- 7.1.7. North America Drug Delivery Devices Market By End User 2016 -2026 (USD Billion)
- 7.2. EUROPE
- 7.2.1. Key Findings
- 7.2.2. Impact of COVID 19
- 7.2.3. Key market trends, growth factors and opportunities
- 7.2.4. Europe Drug Delivery Devices Market by Country 2016 -2026 (USD Billion)
- 7.2.5. Europe Drug Delivery Devices Market By Route of Administration 2016 -2026 (USD Billion)
- 7.2.6. Europe Drug Delivery Devices Market By Application 2016 -2026 (USD Billion)
- 7.2.7. Europe Drug Delivery Devices Market By End User 2016 -2026 (USD Billion)
- 7.3. ASIA PACIFIC
- 7.3.1. Key Findings
- 7.3.2. Impact of COVID 19
- 7.3.3. Key market trends, growth factors and opportunities
- 7.3.4. Asia Pacific Drug Delivery Devices Market by Country 2016 -2026 (USD Billion)
- 7.3.5. Asia Pacific Drug Delivery Devices Market By Route of Administration 2016 -2026 (USD Billion)
- 7.3.6. Asia Pacific Drug Delivery Devices Market By Application 2016 -2026 (USD Billion)
- 7.3.7. Asia Pacific Drug Delivery Devices Market By End User 2016 -2026 (USD Billion)
- 7.4. LATIN AMERICA
- 7.4.1. Key Findings
- 7.4.2. Impact of COVID 19
- 7.4.3. Key market trends, growth factors and opportunities
- 7.4.4. Latin America Drug Delivery Devices Market by Country 2016 -2026 (USD Billion)
- 7.4.5. Latin America Drug Delivery Devices Market By Route of Administration 2016 -2026 (USD Billion)
- 7.4.6. Latin America Drug Delivery Devices Market By Application 2016 -2026 (USD Billion)
- 7.4.7. Latin America Drug Delivery Devices Market By End User 2016 -2026 (USD Billion)
- 7.5. MIDDLE EAST AND AFRICA
- 7.5.1. Key Findings
- 7.5.2. Impact of COVID 19
- 7.5.3. Key market trends, growth factors and opportunities
- 7.5.4. Middle East and Africa Drug Delivery Devices Market by Country 2016 -2026 (USD Billion)
- 7.5.5. Middle East and Africa Drug Delivery Devices Market By Route of Administration 2016 -2026 (USD Billion)
- 7.5.6. Middle East and Africa Drug Delivery Devices Market By Application 2016 -2026 (USD Billion)
- 7.5.7. Middle East and Africa Drug Delivery Devices Market By End User 2016 -2026 (USD Billion)
8. Competitive Landscape Analysis
- 8.1. Global Drug Delivery Devices Market Company Revenue, (USD Billion), 2016-2019
- 8.2. Global Drug Delivery Devices Market Company Share, (%), 2016-2019
9. Company Profiles
- 9.1. Gerresheimer AG
- 9.2. Sanofi
- 9.3. Johnson & Johnson Services, Inc.
- 9.4. Bayer AG
- 9.5. GlaxoSmithKline plc
- 9.6. Enable Injections
- 9.7. West Pharmaceutical Services, Inc.
- 9.8. SMC Ltd.
- 9.9. ViVO Smart Medical Devices Ltd.
- 9.10. Cipla Inc
- 9.11. Novosanis
- 9.12. MEDMIX SYSTEMS AG
- 9.13. Merck & Co., Inc.
- 9.14. Pfizer Inc.
- 9.15. Insulet Corporation
- 9.16. OraSure Technologies, Inc.
- 9.17. BD.
- 9.18. F. Hoffmann-La Roche Ltd
- 9.19. Antares Pharma
- 9.20. Novartis AG
- 9.21. 3M
- 9.22. Sulzer Ltd
- 9.23. Others
10. Appendix
11. List of Tables
12. List of Figures
Summary:
Get latest Market Research Reports on Drug Delivery Devices . Industry analysis & Market Report on Drug Delivery Devices is a syndicated market report, published as Global Drug Delivery Devices Market By Route of Administration [Oral, Injectable, Nasal, Topical, Ocular, Implantable and others],By Application [Infectious Diseases, Autoimmune Diseases, Cancer, Central Nervous System Disorders, Cardiovascular Diseases, Respiratory Diseases ,Diabetes and others], By End User[Hospitals and Clinics, Home Care Settings and Diagnostic Centers]: Market Research Report 2021 Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecas. It is complete Research Study and Industry Analysis of Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
